长链非编码RNA-微小RNA-信使核糖核酸调控轴作为宫颈癌潜在生物标志物的综合概述

LncRNA-miRNA-mRNA regulatory axes as potential biomarkers in cervical cancer: a comprehensive overview.

作者信息

Patel Dimple, Thankachan Sanu, Sreeram Saraswathy, Kavitha K P, Kabekkodu Shama Prasada, Suresh Padmanaban S

机构信息

National Resource Centre for Value Education in Engineering, Indian Institute of Technology, Delhi, Hauz Khas, New Delhi, 110016, India.

Department of Bioscience and Engineering, National Institute of Technology, Calicut, Kerala, 673601, India.

出版信息

Mol Biol Rep. 2025 Jan 8;52(1):110. doi: 10.1007/s11033-024-10215-2.

Abstract

Despite the recent advances in vaccination and treatment strategies, cervical cancer continues to claim numerous lives every year. Owing to the fact that non-coding RNAs (ncRNAs) such as long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) interact with coding transcripts, and effectuate key roles in the tumorigenesis and metastasis of cervical cancer, there has been extensive research in recent years to explore their potential as biomarkers for early detection, or as therapeutic targets. Through this review, we aim to provide a comprehensive overview of the recent advancements in discoveries about cervical cancer-associated lncRNA-miRNA-mRNA axes, their dysregulation, and their roles in various signaling pathways associated with the growth, survival, invasion, and metastasis of cervical cancer cells. We further discuss the potential therapeutic strategies to utilize the dysregulated lncRNAs as diagnostic and prognostic biomarkers, and as therapeutic targets to ameliorate the prognosis of cervical cancer.

摘要

尽管近年来在疫苗接种和治疗策略方面取得了进展,但宫颈癌每年仍夺去众多生命。由于长链非编码RNA(lncRNA)和微小RNA(miRNA)等非编码RNA(ncRNA)与编码转录本相互作用,并在宫颈癌的发生和转移中发挥关键作用,因此近年来人们进行了广泛的研究,以探索它们作为早期检测生物标志物或治疗靶点的潜力。通过这篇综述,我们旨在全面概述宫颈癌相关lncRNA-miRNA-mRNA轴的最新发现进展、它们的失调情况以及它们在与宫颈癌细胞生长、存活、侵袭和转移相关的各种信号通路中的作用。我们还将进一步讨论潜在的治疗策略,即利用失调的lncRNA作为诊断和预后生物标志物,以及作为改善宫颈癌预后的治疗靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索